Search Results - "Livezey, Jeffrey"

Refine Results
  1. 1

    Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno‐venous haemofiltration by Selig, Daniel J., Akers, Kevin S., Chung, Kevin K., Pruskowski, Kaitlin A., Livezey, Jeffrey R., Por, Elaine D.

    Published in British journal of clinical pharmacology (01-05-2022)
    “…Introduction Severe burn injury involves widespread skin and tissue damage leading to systemic inflammation, hypermetabolism and multi‐organ failure. The…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Pharmacokinetics, safety and efficacy of intra‐articular non‐steroidal anti‐inflammatory drug injections for the treatment of osteoarthritis: A narrative review by Selig, Daniel J., Kress, Adrian T., Horton, Isaiah M., Livezey, Jeffrey R., Sadik, Eliot J., DeLuca, Jesse P.

    “…What is known and Objective Osteoarthritis (OA) is a common cause of joint disease and activity limitation in adults. Common therapies to treat OA‐related pain…”
    Get full text
    Journal Article
  4. 4

    Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System by Por, Elaine D., Akers, Kevin S., Chung, Kevin K., Livezey, Jeffrey R., Selig, Daniel J.

    Published in Journal of clinical pharmacology (01-09-2021)
    “…Continuous venovenous hemofiltration (CVVH) is a life‐sustaining procedure in patients with severe burns and acute kidney injury. Physiologic changes from burn…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Evaluation of Pharmacogenomics Testing of Cytochrome P450 Enzymes in the Military Health System From 2015 to 2020 by Por, Elaine D, Selig, Daniel J, Chin, Geoffrey C, DeLuca, Jesse P, Oliver, Thomas G, Livezey, Jeffrey R

    Published in Military medicine (30-12-2021)
    “…ABSTRACT Pharmacogenomics (PGx) plays a fundamental role in personalized medicine, providing an evidence-based treatment approach centered on the relationship…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Applying Pharmacogenomic Guidelines to Combat Medical Care by DeLuca, Jesse, Oliver, Thomas, Hulsopple, Chad, Selig, Daniel, Por, Elaine, Turner, Clesson, Hellwig, Lydia, Livezey, Jeffrey

    Published in Military medicine (01-01-2022)
    “…ABSTRACT Pharmacogenomics is a pillar of personalized medicine that has the potential to deliver optimized treatment in many medical settings. Military…”
    Get full text
    Journal Article
  11. 11

    Prescription Patterns and Relationship to Pharmacogenomics Testing in the Military Health System by Selig, Daniel J, Livezey, Jeffrey R, Chin, Geoffrey C, DeLuca, Jesse P, Guillory II, Walter O, Kress, Adrian T, Oliver, Thomas O, Por, Elaine D

    Published in Military medicine (01-01-2022)
    “…ABSTRACT Introduction Clinical utilization of pharmacogenomics (PGx) testing is highly institutionally dependent, and little information is known about…”
    Get full text
    Journal Article
  12. 12

    Toward Personalized Medicine Implementation: Survey of Military Medicine Providers in the Area of Pharmacogenomics by DeLuca, Jesse, Selig, Daniel, Poon, Lucas, Livezey, Jeffrey, Oliver, Thomas, Barrett, John, Turner, Clesson, Hellwig, Lydia

    Published in Military medicine (02-03-2020)
    “…Abstract Introduction Personalized medicine is the right treatment, to the right patient, at the right dose. Knowledge of genetic predisposition to variable…”
    Get full text
    Journal Article
  13. 13

    Risk of type 2 diabetes mellitus by antimuscarinic agents among adult females receiving care in the military health system by Selig, Daniel J., Brown, Aaron J., DeLuca, Jesse P., Kress, Adrian T., Livezey, Jeffrey R., Oliver, Thomas G., Por, Elaine D., Thelus Jean, Rosenie

    Published in Pharmacoepidemiology and drug safety (01-12-2020)
    “…Purpose To explore patterns of antimuscarinic medication as a risk factor for type 2 diabetes mellitus (T2DM). Methods This is a retrospective cohort study of…”
    Get full text
    Journal Article
  14. 14

    Comparison of Piperacillin and Tazobactam Pharmacokinetics in Critically Ill Patients with Trauma or with Burn by Selig, Daniel J, Akers, Kevin S, Chung, Kevin K, Kress, Adrian T, Livezey, Jeffrey R, Por, Elaine D, Pruskowski, Kaitlin A, DeLuca, Jesse P

    Published in Antibiotics (Basel) (04-05-2022)
    “…Critical illness caused by burn and sepsis is associated with pathophysiologic changes that may result in the alteration of pharmacokinetics (PK) of…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    BRAF mutations are uncommon in papillary thyroid cancer of young patients by Penko, Karen, Livezey, Jeffrey, Fenton, Cydney, Patel, Aneeta, Nicholson, Diarmuid, Flora, Michael, Oakley, Kevin, Tuttle, R Michael, Francis, Gary

    Published in Thyroid (New York, N.Y.) (01-04-2005)
    “…Mortality is low for young patients (younger than 21 years) with papillary thyroid cancer (PTC), and different mutations might contribute to this. Previous…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20